NO994181D0 - S-2'-(2-(1-metyl-2-piperidyl)etyl)cinnamanilid som 5-HT2 reseptor antagonist - Google Patents
S-2'-(2-(1-metyl-2-piperidyl)etyl)cinnamanilid som 5-HT2 reseptor antagonistInfo
- Publication number
- NO994181D0 NO994181D0 NO994181A NO994181A NO994181D0 NO 994181 D0 NO994181 D0 NO 994181D0 NO 994181 A NO994181 A NO 994181A NO 994181 A NO994181 A NO 994181A NO 994181 D0 NO994181 D0 NO 994181D0
- Authority
- NO
- Norway
- Prior art keywords
- mpec
- cinnamanilide
- piperidyl
- ethyl
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/810,503 US5780487A (en) | 1995-08-07 | 1997-02-28 | S-2'- 2-(1-methyl-2-piperidyl) ethyl! cinnamanilide |
PCT/US1998/001304 WO1998038165A1 (en) | 1997-02-28 | 1998-01-23 | S-2'-(2-(1-methyl-2-piperidyl) ethyl) cinnamanilide as a 5-ht2 receptor antagonist |
Publications (3)
Publication Number | Publication Date |
---|---|
NO994181D0 true NO994181D0 (no) | 1999-08-27 |
NO994181L NO994181L (no) | 1999-10-27 |
NO318443B1 NO318443B1 (no) | 2005-03-21 |
Family
ID=25204013
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19994181A NO318443B1 (no) | 1997-02-28 | 1999-08-27 | S-2'-(2-(1-metyl-2-piperidyl)etyl)cinnamanilid som 5-HT2 reseptor-antagonist |
Country Status (11)
Country | Link |
---|---|
US (1) | US5780487A (no) |
EP (1) | EP0973741B1 (no) |
JP (1) | JP3492378B2 (no) |
KR (1) | KR20000075696A (no) |
AT (1) | ATE242765T1 (no) |
AU (1) | AU750603B2 (no) |
CA (1) | CA2282840C (no) |
DE (1) | DE69815518T2 (no) |
ES (1) | ES2201440T3 (no) |
NO (1) | NO318443B1 (no) |
WO (1) | WO1998038165A1 (no) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10036802A1 (de) * | 2000-07-28 | 2002-02-07 | Tesa Ag | Haftklebemassen auf Basis von Blockcopolymeren der Struktur P(A)-P(B)-P(A) |
PL373484A1 (en) * | 2001-12-10 | 2005-09-05 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
US7600626B2 (en) * | 2002-06-13 | 2009-10-13 | Cummins-Allison Corp. | Currency processing and strapping systems and methods |
DE10358525A1 (de) | 2003-12-13 | 2005-07-07 | Bayer Healthcare Ag | Endoparasitizide Mittel zur topischen Applikation |
BRPI0618766A2 (pt) * | 2005-11-17 | 2011-09-13 | Novartis Ag | compostos e a fabricação dos mesmos |
EP1994001A2 (en) * | 2005-11-17 | 2008-11-26 | Novartis AG | Benzeneszkfibate salts and their use as intermediates for the synthesis of 2-[2-(1-alkyl-2-piperidyl)ethyl] cinnamanilides |
MX2011004284A (es) * | 2008-10-22 | 2011-06-21 | Sam Amer & Co Inc | Metodo para tratar la hipertension arterial pulmonar. |
WO2012026914A1 (en) * | 2010-08-23 | 2012-03-01 | Sam Amer & Co., Inc. | Methods and compositions for treating internal and external hemorrhoids |
WO2013070236A1 (en) * | 2011-11-11 | 2013-05-16 | Ventrus Biosciences, Inc. | Methods and compositions for treating hemorrhoids while providing local anesthetic and anti-inflammatory effects |
CN102924374B (zh) * | 2012-02-15 | 2014-04-16 | 湖北欣瑞康医药科技有限公司 | 喹啉-4-羧酸衍生物的制备方法 |
CH706161A1 (de) | 2012-03-15 | 2013-10-15 | Oti Greentech Group Ag | Ölrückgewinnung. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4064254A (en) * | 1971-03-03 | 1977-12-20 | Mead Johnson & Company | Substituted piperidines therapeutic process and compositions |
US4000143A (en) * | 1971-03-03 | 1976-12-28 | Mead Johnson & Company | Substituted piperidines |
US5266571A (en) * | 1992-01-09 | 1993-11-30 | Amer Moh Samir | Treatment of hemorrhoids with 5-HT2 antagonists |
GB9402688D0 (en) * | 1994-02-11 | 1994-04-06 | Merck Sharp & Dohme | Therapeutic agents |
-
1997
- 1997-02-28 US US08/810,503 patent/US5780487A/en not_active Expired - Lifetime
-
1998
- 1998-01-23 CA CA002282840A patent/CA2282840C/en not_active Expired - Fee Related
- 1998-01-23 KR KR1019997007763A patent/KR20000075696A/ko not_active Application Discontinuation
- 1998-01-23 AT AT98903668T patent/ATE242765T1/de not_active IP Right Cessation
- 1998-01-23 AU AU60377/98A patent/AU750603B2/en not_active Ceased
- 1998-01-23 WO PCT/US1998/001304 patent/WO1998038165A1/en not_active Application Discontinuation
- 1998-01-23 ES ES98903668T patent/ES2201440T3/es not_active Expired - Lifetime
- 1998-01-23 EP EP98903668A patent/EP0973741B1/en not_active Expired - Lifetime
- 1998-01-23 JP JP52083598A patent/JP3492378B2/ja not_active Expired - Fee Related
- 1998-01-23 DE DE69815518T patent/DE69815518T2/de not_active Expired - Lifetime
-
1999
- 1999-08-27 NO NO19994181A patent/NO318443B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
ATE242765T1 (de) | 2003-06-15 |
EP0973741B1 (en) | 2003-06-11 |
AU6037798A (en) | 1998-09-18 |
DE69815518D1 (en) | 2003-07-17 |
CA2282840A1 (en) | 1998-09-03 |
US5780487A (en) | 1998-07-14 |
JP2001527521A (ja) | 2001-12-25 |
KR20000075696A (ko) | 2000-12-26 |
NO318443B1 (no) | 2005-03-21 |
CA2282840C (en) | 2006-04-11 |
DE69815518T2 (de) | 2004-04-22 |
NO994181L (no) | 1999-10-27 |
ES2201440T3 (es) | 2004-03-16 |
WO1998038165A1 (en) | 1998-09-03 |
JP3492378B2 (ja) | 2004-02-03 |
EP0973741A1 (en) | 2000-01-26 |
AU750603B2 (en) | 2002-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO950774L (no) | Fremgangsmåte for inhibering av bentap og nedsettelse av serumkolesterol | |
BR0307406A (pt) | Indóis substituìdos como agonistas alfa-1 | |
NO994181L (no) | S-2'-(2-(1-metyl-2-piperidyl)etyl)cinnamanilid som 5-HT2 reseptor-antagonist | |
GEP20033131B (en) | Azabicycloalkanes as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Activity | |
DK0735868T3 (da) | Anvendelse af ikke-steroide cyclooxygenaseinhibitorer til fremstilling af et medikament til behandling af forhøjet intrakul | |
BR0315143A (pt) | Composto, processo para a preparação dos (r) e (s) - enanciÈmeros individuais ou misturas de enanciÈmeros e sais farmaceuticamente aceitáveis de um composto, composição farmacêutica, e, uso de um composto | |
GT199700037A (es) | Composiciones farmaceuticas para el tratamiento de la rinitis | |
IL111127A (en) | Short-acting calcium antagonist dihydropyridines process for their preparation and pharmaceutical compositions containing them | |
BR0013935A (pt) | IsÈmeros oticamente ativos de cetotifeno e metabólitos terapeuticamente ativos dos mesmos | |
ES2102994T3 (es) | Derivados de benzisotiazolinona-1-dioxido como inhibidores de elastasa. | |
IT1250049B (it) | Composti triciclici. | |
RU94046107A (ru) | Замещенные производные 2 бета - морфолинандростана, способ их получения, фармакомпозиция, содержащая их | |
TR200200263T2 (tr) | Yeni seçiçi retinoid agonistleri | |
EA200001061A1 (ru) | Фармацевтическая композиция | |
KR940703655A (ko) | 약제학적 조성물과 그 제조방법 | |
GEP20012389B (en) | Benzoxazinone Dopamine D4 Receptor Antagonists, Pharmaceutical Composition Containing the Same and Method for Treatment of Psychosis or Schizophrenia | |
BR0013582A (pt) | Agonistas retinóides seletivos para rar | |
AU3623399A (en) | Use of benzofuroxan derivatives in treating angina pectoris | |
SE9900190D0 (sv) | New compounds | |
AR008245A1 (es) | Derivados de acido acetico, uso de los mismos en la fabricacion de un agente terapeutico y proceso para preparar dichos derivados | |
ECSP941088A (es) | Composiciones | |
DK0556813T3 (da) | Amfotere tricykliske forbindelser som antihistaminske og antiallergiske midler | |
FI950209A0 (fi) | Farmakologisesti aktiiviset alfa-(tertiaarinen-amino-metyyli)-bentseenimetanolijohdannaiset | |
KR890701584A (ko) | 20, 21-디노르에비나메닌의 신규 치환 유도체, 그의 제조 방법 및 이 방법으로 얻는 신규 중간체, 약제로서의 그의 용도 및 그를 함유하는 제약 조성물 | |
TR200000154T2 (tr) | 2,4,4-Trisübstitüe-1,3-Dioksolan mantar önleyiciler. |